Person

Steven R. Loranger

Director, Edwards Lifesciences

Current S&P 500 boards
1
Current roles
1
Open-market buys
$505K
Open-market sales
$23.6M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 14, 2025EWSale5,739$76.42$439K
Sep 11, 2020XYLSale18,388$83.95$1.5M
Feb 12, 2020XYLSale30,000$88.61$2.7M
Mar 15, 2019XYLSale10,000$76.99$770K
Dec 20, 2017XYLSale12,120$68.14$826K
Dec 19, 2017XYLSale5,019$68.00$341K
Dec 18, 2017XYLSale47,712$68.10$3.2M
Dec 13, 2017XYLSale200$68.02$14K
Dec 11, 2017XYLSale196$68.23$13K
Nov 6, 2017XYLSale37,700$66.25$2.5M
Jun 29, 2017XYLSale9,933$55.05$547K
Jun 28, 2017XYLSale56,199$55.00$3.1M
Aug 11, 2016XYLSale28,732$48.13$1.4M
Aug 10, 2016XYLSale5,155$48.00$247K
Jul 28, 2016XYLSale32,246$48.01$1.5M
Jun 1, 2016XYLSale50,000$44.52$2.2M
May 27, 2016XYLSale50,000$44.67$2.2M
May 24, 2016EWBuy5,000$101.07$505K

SEC reporting-owner ID (CIK) 1226924 · all filings on EDGAR

Steven R. Loranger (EW) | USBoard